{"product_id":"2940013782761","title":"Oxycodone, Hydrocodone, and Polydrug Use, 2002","description":"In recent years, the abuse of opioid pain relievers1 has been recognized as a serious and growing public health problem.2,3 Recent estimates from the Drug Abuse Warning Network (DAWN) showed that drug abuse-related emergency department (ED) visits involving opioid pain relievers have been increasing since 1994. Two of these pain relievers, oxycodone and hydrocodone,4 account for a substantial proportion of the increase (Figure 1).\u003cbr\u003e■ In 2002, opioid pain relievers accounted for more than 119,000 ED mentions, or 10 percent of all the drug mentions in drug abuse-related ED visits. Oxycodone and hydrocodone were the most frequently named pain relievers, accounting for 40 percent (47,594 mentions) of the opioid pain relievers involved in these ED visits.\u003cbr\u003e■ Approximately three-quarters of ED visits involving oxycodone and hydrocodone involved additional drugs (71% and 78%, respectively), while only 54 percent of all drug abuse-related visits involved multiple drugs.\u003cbr\u003e■ The most frequent substances found in combination with oxycodone and hydrocodone in drug abuse-related ED visits were alcohol, benzodiazepines, other opioid pain relievers, and cocaine.","brand":"The Delano Max Wealth Institute, LLC.","offers":[{"title":"Default Title","offer_id":47079722254576,"sku":"2940013782761","price":1.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0737\/7593\/9824\/files\/2940013782761_p0.jpg?v=1763599124","url":"https:\/\/shop-qa.barnesandnoble.com\/products\/2940013782761","provider":"Barnes \u0026 Noble (DEV)","version":"1.0","type":"link"}